FDA forwards Avandia 'conflict' probe to HHS

Share this article:
As it wrestles with the drug's safety issues, including public disagreements about them within its own ranks, FDA referred in July to the HHS Office of Inspector General the case of an Avandia advisory committee panel member who had an alleged conflict of interest related to previous work performed on behalf of GlaxoSmithKline that was not disclosed.

Endocrinologist David Capuzzi was one of only three committee members to vote to recommend that Avandia remain on the market with no new labeling or restrictions on its use. He reportedly received payments from GSK for speaking engagements he performed for them.

“FDA has completed its fact-gathering process and has referred the Dr. Capuzzi matter to the HHS Office of Inspector General,” FDA spokeswoman Karen Riley said. “FDA is prohibited by law to release Dr. Capuzzi's or any member's confidential financial disclosure form.”

Capuzzi has said he wasn't specifically asked about his work with GSK that involved an unrelated drug. Capuzzi also said that in his own practice he doesn't prescribe Avandia or any newer diabetes drug, preferring to use older metformin drugs.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.